Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Elsevier and Russia's Ural Federal University Sign License Agreement for Pure

MOSCOW, April 22, 2014 /PRNewswire/ --

First Russian university to have access to Elsevier's research information management system 

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced it has reached an agreement with Russia's Ural Federal University (UrFU) to provide its researchers, faculty members and management with access to Pure, a research information management system to enable evidence-based decisions, promote collaboration, simplify administration and optimize impact. Pure is part of the Elsevier Research Intelligence portfolio of tools and services.

Over the years, UrFU, one of the leading Russian universities, has focused on increasing the quality and quantity of its research output with the aim of increasing its position in the world research rankings. With access to Pure, UrFU researchers, faculty members and management can improve transparency in their research processes, monitor and facilitate collaboration and track the university's research outcomes, including awarded grants, publications and research output and impact. Furthermore, the customized dashboards and flexible reporting capabilities will help managers make more strategic, evidence-based decisions to improve the university's performance.

Viktor Koksharov, UrFu's Rector, said, "Pure will allow us to share our accomplishments with the global scientific community. Centrally collecting research information will give us more insights to enable us to increase the efficiency of research management in the university."

Igor Osipov, PhD, Regional Director at Elsevier Russia and Belarus, added, "We welcome the innovative approach UrFu is taking for their future development. We are pleased to extend our collaboration with the university and bringing Pure to the Russian market for the first time. We are confident that with access to Pure the university can further optimize their efforts to expand their global reputation."

AboutUral Federal University 

Ural Federal University (UrFU) is the oldest higher educational institution in the Ural region.  It was founded in Ekaterinburg in 1920. Since 2008 the Ural University has carried the name of Boris Yeltsin, its graduate of 1955, elected by the people in 1991 to be the first President of Russia. UrFU is one of the top ranked scientific centres in Russia, carrying out research in natural, technical, and social sciences, the humanities, and economics. The University includes 17 institutes offering about 350 programs. UrFU research facilities include dozens of research centres, innovation infrastructure, the research library boasting a collection of over three million books, several museums, and specialised collections. The total number of students at UrFU exceeds 28,000.

About Elsevier Research Intelligence 

Elsevier Research Intelligence is a comprehensive research information management portfolio which improves the ability to establish, execute, and evaluate research strategies.  The portfolio includes the new-generation SciVal tools, the Pure system, and our custom Analytical Services, as well as rich data assets like Scopus, and the reference management technology of Mendeley. Elsevier Research Intelligence enables research organizations, funders, policy-makers, and individual researchers make better decisions, improve collaboration, attract investment, and optimize expenditure - all to enhance research strategy, execution, and performance.

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Galina Yakshonak
Elsevier, Russia
+7-985-72-779-67
g.yakshonak@elsevier.com